CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Mspi polymorphisms (rs4646903) of the cyp1a1 gene in women infected with human papillomavirus in West Africa

Author: 
Mah Alima Esther TRAORE (PhD student), Wendkuuni Florencia DJIGMA (PhD), Marius Ayaovi SETOR (PhD student), Théodora Mahoukèdè ZOHONCON(MD, PhD), Dorcas OBIRI-YEBOA (MD, PhD), Abdoul Karim OUATTARA (PhD), Pegdwendé Abel SORGHO (PhD), Prosper BADO (PhD s
Subject Area: 
Health Sciences
Abstract: 

Background: Human papillomavirus (HPV) infection alone is not enough to induce malignant transformation due to viral clearance. Genetic factors could play a very important role in the progression. Genes such as cytochrome P450 1A1 (CYP1A1) could affect the progression of cervical lesions. The objectives of this study were to screen HPV-positive women and to determine CYP1A1 gene polymorphisms in human papillomavirus infections in West African women. Methods: For this study, a total of 1215 samples taken from endocervical cells, were collected. The women came from 5 countries in West Africa. These samples were analyzed by multiplexed real-time PCR to search for fourteen high-risk HPV genotypes (HR-HPV). The mono-nucleotide polymorphism MspI was determined using the RFLP PCR technique. Results: Of the 1215 swab specimens, 367 (30.28 %) were HPV positive and 848 (69.80 %) HPV negative. High-risk characterized genotypes were in descending order: HPV 66 (12.81 %), HPV 59 (10.85 %), HPV 52 (10.68 %), HPV 51 (9.25 %), HPV 45 ( 7.83 %), HPV 39 (6.94 %), HPV 56 (6.05 %), HPV 35 (5.87 %), HPV 58 (5.87 %), HPV 18 (5.52 %) , HPV 31 (3.38 %), HPV 33 (2.49 %), HPV 16 (2.14 %). This study also revealed the presence of the CYP1A1 genotype in women with HR-HPV infection. It also showed a decrease in the frequency of CC genotype in women with HR-HPV infection (3.45 %) compared with controls (7.28 %). Conclusion: This study showed a high prevalence of HPV 66, HPV 35 and HPV 59. The prevalence of HPV 18 and HPV 16 are among the lowest in this study. However, the results of the research demonstrated that the rs4646903 mutation of the CYP1A1 gene was not statistically related to a risk of acquiring HPV infection in the West African population.

PDF file: 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran